Aug 7, 2025 04:13PM Cytosorbents (CTSO) Misses Q2 EPS by 1c

Jul 2, 2025 07:00AM Cytosorbents (CTSO) Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

Jun 24, 2025 07:00AM Cytosorbents (CTSO) Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

May 22, 2025 09:28AM Cytosorbents (CTSO) Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

May 14, 2025 04:03PM Cytosorbents (CTSO) Misses Q1 EPS by 1c

May 1, 2025 04:16PM Cytosorbents (CTSO) Provides Regulatory Update for DrugSorb-ATR

Apr 21, 2025 07:00AM Cytosorbents (CTSO) Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

Apr 4, 2025 07:00AM Cytosorbents (CTSO) Extends Expiration Date of Outstanding Series B Right Warrants

Mar 31, 2025 04:17PM Cytosorbents (CTSO) Tops Q4 EPS by 2c, Misses on Revenue

Mar 4, 2025 07:02AM Cytosorbents (CTSO) Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

Feb 25, 2025 07:02AM Cytosorbents (CTSO) Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

Jan 6, 2025 07:02AM Cytosorbents (CTSO) Opens New Regional Sales Subsidiary in Dubai

Jan 3, 2025 07:00AM Cytosorbents (CTSO) Reports Prelim Q4 Revenue

Dec 23, 2024 07:03AM Cytosorbents (CTSO) Begins Rights Offering

Dec 9, 2024 07:00AM Cytosorbents (CTSO) Announces Rights Offering

Nov 11, 2024 07:31AM Cytosorbents (CTSO) and Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

Oct 22, 2024 07:03AM Cytosorbents (CTSO): FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

Oct 2, 2024 06:35AM B.Riley Reiterates Buy Rating on CytoSorbents (CTSO)

Oct 1, 2024 07:00AM Cytosorbents (CTSO) Submits DrugSorb-ATR Marketing Application to U.S. FDA

Sep 26, 2024 05:20PM Cytosorbents (CTSO) Files $150M Mixed Shelf

Aug 13, 2024 04:22PM Cytosorbents (CTSO) Tops Q2 EPS by 1c

Aug 13, 2024 04:19PM Cytosorbents (CTSO) Appoints Peter J. Mariani as CFO

Aug 1, 2024 07:03AM Cytosorbents (CTSO) Regains Nasdaq Compliance

Jul 29, 2024 07:02AM EF Hutton Starts CytoSorbents (CTSO) at Buy

Jul 2, 2024 07:02AM Cytosorbents (CTSO) Enters $20M Credit Facility

Jun 24, 2024 07:03AM Cytosorbents (CTSO) Announces Regulatory Approval of CytoSorb in Taiwan